UNSPSC 85523807: Supplement left basilic vein with nonautologous tissue substitute, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement left basilic vein with nonautologous tissue substitute, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 05UC3KZ

UNSPSC 85523807 Supplement left basilic vein with nonautologous tissue substitute, percutaneous approach is a Commodity code that appears to describe a specific surgical procedure. However, the recent state and local contract opportunities posted under this code show no procurement activity aligned with the code's nominal scope. Instead, the opportunities span independent medical evaluation services, health plan surgical benefit carve-outs, occupational medical surveillance, emergency and specialty medical services for detained youth, pharmacy benefit management, and temporary health professional staffing — none of which involve vascular surgery or tissue supplementation. The code shows little relevant recent activity; the mismatch between the code's clinical descriptor and the work actually being solicited suggests either a systematic tagging error or that this code is not actively used by state and local purchasing offices for medical procurement.

The recent opportunities that carry this code designation originate from diverse issuing bodies including city retirement offices (City of Phoenix), municipalities (City of Long Beach), state transportation departments (Washington State Department of Transportation), county juvenile justice systems (Harris County), county health systems (Collier County, County of Santa Clara), and county commissioners' offices across Arizona, California, Florida, and Washington. No geographic concentration or repeat buyer pattern emerges. The opportunities show activity in Arizona, California, Florida, and Washington through August and September 2026, with response dates extending through October and beyond. Given the absence of vascular-surgery-related procurement in the available records and the categorical mismatch between the code name and the opportunities posted under it, this code does not represent an active or relevant procurement category for business development purposes at this time.